Evidence map›Paper›PMID 27186426›Full record

ReviewAmerican journal of cancer research2016

Paradoxical role of SOX2 in gastric cancer.

Estefania Carrasco-Garcia, Juliana C Santos, Idoia Garcia, Mitsue Brianti, Mikel García-Puga, José Pedrazzoli, Ander Matheu, Marcelo L Ribeiro

Open access · greenAbstract readReview
In one paragraph

Review in American journal of cancer research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Functional characterization of SOX2 as an anticancer target.Signal transduction and targeted therapy · 2020
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Claudin-6 is down-regulated in gastric cancer and its potential pathway.Cancer biomarkers : section A of Disease markers · 2020
    Article
  14. Review
  15. Article
  16. MutatedCancers · 2019
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Estefania Carrasco-GarciaNeurooncology group, Biodonostia Health Research Institute Paseo Dr. Beguiristain s/n, San Sebastian 20014, Spain.
Juliana C SantosUnidade Integrada de Farmacologia e Gastroenterologia, Universidade São Francisco Bragança Paulista, SP, Brazil.
Idoia GarciaNeurooncology group, Biodonostia Health Research InstitutePaseo Dr. Beguiristain s/n, San Sebastian 20014, Spain; IKERBASQUE, Basque FoundationSpain.
Mitsue BriantiUnidade Integrada de Farmacologia e Gastroenterologia, Universidade São Francisco Bragança Paulista, SP, Brazil.
Mikel García-PugaNeurooncology group, Biodonostia Health Research Institute Paseo Dr. Beguiristain s/n, San Sebastian 20014, Spain.
José PedrazzoliUnidade Integrada de Farmacologia e Gastroenterologia, Universidade São Francisco Bragança Paulista, SP, Brazil.
Ander MatheuNeurooncology group, Biodonostia Health Research InstitutePaseo Dr. Beguiristain s/n, San Sebastian 20014, Spain; IKERBASQUE, Basque FoundationSpain.
Marcelo L RibeiroUnidade Integrada de Farmacologia e Gastroenterologia, Universidade São Francisco Bragança Paulista, SP, Brazil.
Unidade Integrada de Farmacologia e Gastroenterologia · BRBiogipuzkoa Health Research Institute · ESIkerbasque · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sox2 is a critical regulator of embryogenesis and necessary for cellular reprogramming. It also plays an important role in tissue homeostasis and regeneration, maintaining the population of undifferentiated adult stem cells. Like various developmental and stem cell genes, SOX2 is aberrantly expressed and amplified in several human cancers. Moreover, functional studies have shown that it regulates many biological processes including cell proliferation, apoptosis, self-renewal and invasion. While it is oncogenic in most cancers, SOX2 activity is controversial in gastric cancer, where it might behave as a tumor suppressor in some situations. In this review, we discuss its role in cancer biology, with particular attention to what is known about the involvement of SOX2 in gastric cancer biology.

Indexed as

gastric cancerH. pyloriSOX2stem cells

Identifiers

PMID27186426
PMCPMC4859879
OpenAlexW2399293392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.